Welcome to our dedicated page for Bruker SEC filings (Ticker: BRKR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Bruker Corporation filings document financial results, capital returns, governance actions and proxy matters for a scientific instruments and diagnostics company.
Recent Form 8-K disclosures cover quarterly and annual operating results, outlook commentary, segment information for Bruker Scientific Instruments and Bruker Energy & Supercon Technologies, and dividends on common stock and 6.375% Mandatory Convertible Preferred Stock, Series A. The definitive proxy statement covers board elections, executive compensation, pay-versus-performance data, shareholder voting items and governance practices. Other material-event filings record board composition changes and executive transition arrangements.
Bruker Corp executive Mark Munch reported an option exercise and related share sale. He exercised stock options to acquire 2,000 shares of Common Stock at $22.19 per share and on the same day sold 2,000 shares in an open‑market transaction at $54.76 per share.
The filing notes that the sales were made under a pre‑arranged Rule 10b5‑1 trading plan. Following these transactions, Munch directly holds 128,443 shares of Bruker Common Stock.
Broker Technologies, Inc. (BRKR) notice of proposed sale of 2,000 shares of Common Stock via a stock option exercise to the issuer for cash, dated 06/15/2026. The filing lists prior sales by Mark R. Munch of 2,000 shares on 05/15/2026 for $87,800.00 and 2,000 shares on 04/15/2026 for $79,800.00.
The notice describes the proposed sale method as an exercise through Morgan Stanley Smith Barney LLC and records the transaction party as the issuer. This is an affiliate resale notice under standard procedures and the excerpt does not state any proceeds recipient beyond the issuer or broader strategic implications.
Bruker Corporation has filed a shelf registration on Form S-3 to register an unlimited aggregate amount of securities for offer and resale from time to time, including common stock, preferred stock, debt securities, warrants, units, depositary shares, subscription rights and purchase contracts. Selling stockholders may also offer shares pursuant to supplements.
The prospectus states that specific terms, amounts, offering prices and whether proceeds will be received by Bruker or selling holders will be set forth in prospectus supplements; unless a supplement states otherwise, proceeds from sales by selling stockholders will not be received by Bruker.
Bruker Corporation filed an amended current report to add missing Inline XBRL tags on the cover page for its 6.375% Mandatory Convertible Preferred Stock, Series A. The amendment does not change any prior disclosures.
At the 2026 Annual Meeting held on May 21, 2026, stockholders elected three Class II directors to terms ending at the 2029 Annual Meeting. Laura A. Francis received 136,149,316 votes for and 4,841,094 withheld, John J. Phillips received 139,036,356 for and 1,954,054 withheld, and Hermann F. Requardt received 129,777,851 for and 11,212,559 withheld.
Stockholders approved, on an advisory basis, 2025 compensation for named executive officers with 127,190,553 votes for, 5,748,270 against and 60,390 abstentions. They also ratified PricewaterhouseCoopers LLP as independent auditor for fiscal 2026 by 138,544,738 votes for, 618,216 against and 29,744 abstentions.
Bruker Corporation reported the results of its 2026 Annual Meeting of Stockholders held on May 21, 2026. Stockholders elected three Class II directors — Laura A. Francis, John J. (Jack) Phillips, and Hermann F. Requardt, Ph.D. — each to serve three-year terms ending at the 2029 annual meeting.
Stockholders approved, on an advisory basis, the 2025 compensation of the company’s named executive officers, with 127,190,553 votes for, 5,748,270 against, and 60,390 abstentions, plus 6,193,485 broker non-votes. They also ratified the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal 2026, with 138,544,738 votes for, 618,216 against, and 29,744 abstentions.
Bruker Corp director Bernard Thierry reported an equity award of 2,886 shares of Common Stock in the form of Restricted Stock Units (RSUs). The RSUs were granted at no cash cost to him and represent stock-based compensation.
The RSUs will vest in one installment on May 15, 2027, and on that date each RSU will automatically convert into one share of Bruker Common Stock. Following this grant, Thierry holds 2,886 shares directly, reflecting this new award only and indicating a routine compensation-related acquisition rather than an open-market purchase.
Bruker Corporation executive Mark Munch, EVP and President of Bruker Nano Inc., exercised stock options for 2,000 shares at $22.19 and sold 2,000 shares of common stock at $43.90 on May 15, 2026. After these transactions, he held 128,443 shares and 8,000 stock options. The sale was made under a pre-arranged Rule 10b5-1 trading plan.
Bruker Corporation announced that its Board of Directors has declared a quarterly cash dividend on its common stock of $0.05 per share. The dividend was declared on May 14, 2026 and will be paid on July 7, 2026 to shareholders of record at the close of business on June 22, 2026. The dividend applies to Bruker’s common stock with a par value of $0.01 per share.
Notice of proposed sale of common stock under Rule 144. The filing lists 2,000 shares proposed for sale via a stock option exercise on 05/15/2026 with payment indicated as cash. The record includes two prior sales of 2,000 shares each on 04/15/2026 and 03/13/2026 with proceeds of $79,800 and $70,880, respectively.
Bruker Corp reports that Orbis Investment Management Ltd, Allan Gray Australia Pty Ltd and Orbis Investment Management (U.S.), L.P. together beneficially own 17,940,076 shares of Common Stock, equal to 11.8% of the class as disclosed in this Schedule 13G/A amendment.
The filing breaks down voting and dispositive power: Orbis Investment Management Ltd holds 16,852,868 shares of sole voting and dispositive power; Orbis Investment Management (U.S.), L.P. holds 1,058,886 shares; Allan Gray Australia Pty Ltd holds 28,322 shares. The reporting persons state they do not treat themselves as a Section 13(d)(3) group and each disclaims ownership of shares reported by the others.